Close Menu

NEW YORK (GenomeWeb) – Precision Therapeutics announced this week that it has completed its merger with Helomics, which has become Precision's wholly owned subsidiary. The merger provides Precision with full access to Helomics' suite of artificial intelligence, precision medicine, and integrated CRO capabilities.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

US National Institutes of Health Director Francis Collins says he will avoid male-only speaker panels.

Two patients fell ill, and one subsequently died, following a fecal microbiome transplant that harbored multi-drug-resistant bacteria, according to the New York Times.

Technology Review reports that eGenesis is testing whether organs from genetically modified pigs can be transplanted into monkeys.

In Science this week: almond reference genome, and more.